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Does prolonged protein restriction preceding dialysis lead to protein
malnutrition at the onset of dialysis? It has recently been suggested that
prolonged protein restriction preceding dialysis may induce protein
malnutrition and thus confer a poor prognosis during dialysis. We
examined the records of all patients who were prescribed a very low
protein diet (0.3 g/kg ideal body weight) plus supplemental essential
amino acids and/or ketoacids for 6 to 72 months (median 26 months)
preceding renal replacement, numbering 43. Hypoalbuminemia imme-
diately preceding dialysis was present in only two patients. Final serum
albumin averaged 4.1 0.4 (SD) g/dl. Final transferrin was subnormal in
eight patients, but had been subnormal in six of these, without attendant
hypoalbuminemia, for one to four years. Mean final transferrin was 241
56 mg/dl. Final serum cholesterol was below 150 mg/dl in six
subjects, all of whom had normal levels of albumin (mean 4.0 0.2 g/dl)
and a normal mean value for transferrin (211 22 mg/dl). In five
patients who exhibited subnormal albumin and transferrin and high
cholesterol concentrations at the beginning of dietary therapy, albumin
and transferrin levels rose to normal or nearly normal, and hypercho-
lesterolemia receded during the ensuing four months. Thus this pre-
dialysis dietary regimen, rather than causing protein malnutrition,
prevents it; when protein malnutrition is present, this regimen corrects it.
Even though protein-restricted diets have been known for
decades to reduce symptoms in chronic renal failure, as re-
viewed by Bergstrom [1], their utilization in such patients is far
from universal. One reason is concern that prolonged consump-
tion of a low protein diet may cause protein malnutrition, as
recently pointed out by Hakim and Levin [2]. 1-lypoalbumine-
mia is now known to be the single greatest risk factor for death
during dialysis [3—7].
Having followed patients on very low protein diets supple-
mented by essential amino acids or ketoacids for some years,
we now have records on 43 who have gone on to renal
replacement therapy. We therefore undertook to document
their protein nutrition at the termination of nutritional therapy
and beginning of dialysis or transplantation. We also examined
the records of five patients who exhibited protein malnutrition
before the start of nutritional therapy. The results show that
rather than causing protein malnutrition, this regimen prevents
it and can also correct it.
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Methods
Records of all 43 patients who were prescribed a very low
protein (0.3 glkg ideal body weight) diet plus supplemental
amino acids or ketoacids for six months or longer, who then
went on to dialysis (41 patients) or transplantation without
preceding dialysis (2 patients), were examined. The decision
when to initiate dialysis was made by the director of the dialysis
unit, using the same clinical criteria as were applied to patients
not on dietary treatment.
Initial serum creatinine concentration was 4.8 1.6 mgldl.
Results of sequential determinations of glomerular filtration rate
and other measurements in most of these patients during
nutritional therapy appear in previous reports from this labora-
tory [8—12]. Mean values throughout dietary therapy were
calculated for each patient and averaged across patients for
17-hydroxycorticoid excretion, free cortisol excretion, urea N
excretion, serum albumin, serum transferrin, and serum CO2.
Final values immediately preceding renal replacement were
summarized for serum albumin, transferrin, cholesterol, urea N
and creatinine. Since most patients were given amino acid or
ketoacid supplements alternately, no attempt was made to
differentiate between the number of months during which each
of these two supplements was consumed.
The diet has been described in detail elsewhere, as has the
composition of the supplements and the use of multivitamins
and CaCO3 [8—12]. Patients were seen 5 to 12 times a year by
the author, and by the dietician several times at the outset and
thereafter on request of patient or physician. Caloric prescrip-
tion was generally 35 kcallkg ideal body weight, but was lower
in subjects who desired to lose weight. Calorie counts during
treatment were performed only when undesirable weight loss
occurred. Only one patient developed hypoalbuminemia during
treatment (other than the two patients who developed hy-
poalbuminemia just before dialysis, as detailed in Results).
Supplement dosage was doubled and serum albumin returned to
normal.
Five patients who were hypoalbuminemic when first seen
were reviewed in greater detail. Before treatment, proteinuria
in these patients averaged 7.1 4.2 glday. Four of these are
among the 43 included in the preceding analysis; the fifth was
excluded because he completed fewer than six months of
nutritional therapy before going on dialysis. These five patients
were treated with the same regimen, except that three of them
received 20 g per day of essential amino acids instead of 10 g per
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day. Values for serum albumin, transferrin, cholesterol and
24-hour protein excretion were measured monthly and averaged
across patients.
Prealbumin was not measured. Creatinine-height index was
not used because, even when corrected for age, it is a highly
unreliable measure of muscle mass in the presence of chronic
renal failure [131. Low values are commonly seen at GFR's
below 25 mllmin, but the roles of decreased protein intake,
increased creatjnine metabolism and reduced muscle mass in
causing these low values are uncertain [14].
All measurements were performed by the Johns Hopkins
Hospital Chemistry Laboratory, using automated methods.
Means and standard deviations are reported. Changes in
nutritional parameters were evaluated by Student's t-test for
paired samples.
Results
Follow-up periods
The distribution of follow-up times is shown in Figure 1. The
median was 26 months.
Final albumin concentrations
The distribution of final serum albumin levels is depicted in
Figure 2. Only two patients had values below 3.4 gldl. Both of
them became hypoalbuminemic in the final month preceding
dialysis, during which they were anorexic and vomiting. In
retrospect, they should probably have been started on dialysis
earlier.
Final serum albumin was not correlated with the duration of
protein restriction (Table 1).
Final transferrin concentrations
Final serum transferrin values are depicted in Figure 3. Eight
patients had levels below 200 mg/dl, including the two hypoal-
buminernic patients. In the other six patients, examination of
earlier values for transferrin and albumin reveals that four of
them had exhibited similar values for transferrin for one to four
years, without hypoalbuminemia. The remaining two patients
developed subnormal levels of transferrin only in the final
months. Even though albumin levels remained normal, it is
conceivable that the decrease in transferrin in these two pa-
tients was a sign of impending protein deficiency.
Final cholesterol concentrations
Final values for serum cholesterol are depicted in Figure 4.
Six patients had levels below 150 mg/dl, all of whom had normal
levels of albumin (mean 4.0 0.2g/dl) and a normal mean value
for transferrin (211 22 mg/dl). Cholesterol concentration was
significantly (P < 0.05) correlated with transferrin concentra-
tions (Table 1).
Other measurements
Final serum urea N was 82 24 mg/dl. Final serum creatinine
was 8.8 2.3 rng/dl. These values were significantly correlated,
as expected, but were not correlated with the nutritional
parameters except that final serum urea N was correlated with
urinary urea N (Table 1).
Body mass index (weightlheight2) averaged 24 4 kg/rn2.
Body weight decreased by 0.14 0.26 kg/month (P < 0.001),
but a number of patients (for example, Fig. 5 in [10]) voluntarily
restricted their caloric intake in order to lose weight. Weight
loss was not correlated with nutritional parameters. Average
serum albumin during treatment (4.2 0.3 g/dl) was slightly
higher (by 0.12 0.32 g/dl, P <0.02) than final serum albumin.
The average value during treatment for serum transferrin was
not significantly different from the final value, 241 56 mg/dl.
Average serum CO2 during treatment was 24 4 mri. Average
urine urea N was 5.0 1.2 g/day (range 2.9 to 8.3 g/day),
indicating an average estimated protein intake of 34 g (the
supplements contained 1.4 to 1.8 g N). Protein intake estimated
in this way was significantly correlated with final serum urea N
and with 17-hydroxycorticoid excretion (as we have reported
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Fig. 1. Distribution of follow-up times on diet (months). "Midpoint"
means midpoint of range for each vertical bar. Hence the first bar
signifies 6 to 18 months on diet (patients followed less than 6 months
were excluded).
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Abbreviations are: Mos, months of protein restriction; SUN, final
serum urea N; Cr, final serum creatinine; Aib, final serum albumin;
Trans, final serum transferrin; Chol, final serum cholesterol; 170H,
average 17-hydroxycorticoid excretion during diet; Coil, average free
cortisol excretion during diet; UNA, average urinary urea N excretion
during diet; CO>, average serum CO2 during diet; NS, not significant.
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Fig. 2. Distribution offinal values for serum albumin, gidi. Midpoint as
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Table 1. Correlation coefficients between measured parameters
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Fig. 3. Distribution of final values for serum transferrin,mg/dl. Mid-
point as defined in Figure 1 legend.
previously in [91) but not with other parameters (Table 1).
17-Hydroxycorticoid excretion averaged 3.3 1.1 mg/day
(normal 3 to 9 mg/day). Free cortisol excretion averaged 24 4
pg/day (normal 25 to 125 gIday).
Sequential data in five hypoalbuminemic patients
At the start of protein restriction, mean values for serum
albumin, transferrin and cholesterol in these five patients were
3.1 0.3 g/dl, 208 36 mg/dl, and 282 80 mg/dl, respectively.
During four months of nutritional therapy albumin levels rose to
normal in four of the five patients. The final mean was 3.5 0,4
g/d1. Transferrin also rose to normal in four of the five patients;
the final mean was 242 28 mg/dl. Serum cholesterol fell from
282 80 to 205 43 mg/dl. The significance of paired changes
in all three parameters is shown in Figure 5. Urinary protein
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Cholesterol midpoint
Fig. 4. Distribution of final values for serum cholesterol, mg/dl. Mid-
point as defined in Figure 1 legend.
excretion decreased 32%, but the change was not statistically
significant.
Discussion
In these 43 patients followed 6 to 72 months on severe protein
restriction plus supplemental amino acids or ketoacids, signs of
protein malnutrition at the onset of renal replacement are rare.
At the most, four patients may have been (or were about to
become) protein-deficient. In two of these, anorexia and vom-
iting during the last month of follow-up was the probable cause.
Thus, protein malnutrition was clearly not induced by this
regimen.
In contrast, hypoalbuminemia is seen in 25 to 50% of patients
entering dialysis nationwide [3—7]. How many of these were
restricting protein intake prior to dialysis is conjectural, but it
Time, months
Fig. 5. Sequential observations during nutritional therapy in five pa-
tients who were hypoalbuminenic at the start. Shaded areas represent
part of the normal range for each parameter. Significance of changes
from time zero indicated as follows: * < 0.01; < 0.05.
may be safely assumed that very few were prescribed the
supplemented low protein diet utilized in the present study.
Long-term observation of pre-dialysis patients following reg-
imens identical or similar to the present regimen has generally
found no signs of protein malnutrition [8—22], with one excep-
tion [23] in which protein intake was more severely restricted
(to 0.2 glkg). The results of different measures of protein
nutrition in this latter study [23] were inconsistent. None of
these studies reports final values for nutritional parameters at
the onset of dialysis.
If replacement of a substantial portion of dietary protein by
essential amino acids or ketoacids improves protein nutrition,
as these results indicate, the question arises as to whether some
constituent of proteinaceous foods contributes to protein mal-
nutrition. Accumulation of uremic toxins derived from food
protein may contribute to anorexia, thereby leading to inade-
quate energy intake. Speculatively, glucocorticoids may play a
E
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role. It is clear that intake of whole protein stimulates glucocor-
ticoid production [24—26, Table 1]. High physiological levels of
glucocorticoids can increase protein breakdown [27, 28] and
cause negative N balance [29, 30]. No comparison of pure
essential amino acids with whole protein in their propensity to
stimulate glucocorticoid production has apparently been re-
ported, but it is possible that less stimulation occurs with amino
acids. Steroid excretion rates in the present subjects were
generally low, as has been reported previously in pre-dialysis
patients [9, 31].
The five hypoalbuminemic patients studied were not severely
nephrotic (mean proteinuria 7.1 g/day), but it is likely that
proteinuria was the cause of their protein deficiency. The
optimal diet to improve hypoalbuminemia in nephrotic patients
remains uncertain. Protein restriction is known to reduce pro-
teinuria [32], perhaps by reducing glucocorticoid production
[24—26], which increases proteinuria [33—35]. Nephrotic patients
may benefit from protein restriction plus supplementation with
essential amino acids and/or ketoacids in terms of proteinuria
and hyperlipidemia, but no improvement in hypoalbuminemia
has been found [36, 37]. Whether double doses of essential
amino acids plus protein restriction can improve hypoalbumin-
emia in frankly nephrotic patients remains to be determined.
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